ROCK2 Inhibition With Belumosudil (KD025) for the Treatment of Chronic Graft-Versus-Host Disease.

J Clin Oncol · 2021 · PMC8189612 · PMID 33877856

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

PD Analyses In exploratory PD analyses of peripheral blood mononuclear cells across cohorts, the percentage of CD4 + Tregs demonstrated an increasing trend early on by cycle 2 day 1 of belumosudil treatment.

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.